• Home
  • About us
  • Our products
  • Your health
  • Responsibility
  • In the community
  • Research & development
  • Investors
  • Media centre
  • Careers
GlaxoSmithKline logo

Summary of indicators

These are the main indicators we use to track our performance on a range of corporate responsibility issues.

Issue 2002 2003 2004
Medicines for the Developing World
Supply arrangements for preferentially priced anti-retrovirals (ARVs) 124 175 208
Number of countries supplied with preferentially priced ARVs 50 56 57
Number of Combivir tablets shipped (millions) 6.2 10.7 32.7
Number of albendazole tablets donated (millions) 66 94 67
Number of countries supplied with albendazole 31 34 34
Community investment
Total community investment expenditure
(£ millions)
239 338 328
Value of humanitarian product donations, including albendazole (£ millions) 24 116 57
Value of products donated through GSK Patient Assistance program (£ millions) 112 125 203
Business Ethics and Integrity
Number of employees completing certification to Code of conduct 700 9,000 9,600
Environment
Number of contract manufacturers audited 16 28 35
Energy consumption (million gigajoules) 20.0 19.9 19.0
Water consumption (million cubic metres) 24.4 23.0 20.5
Ozone depletion potential from metered dose inhalers (tonnes CFC-11 equivalent) 1,500 782 464
Ozone depletion potential from production (tonnes CFC-11 equivalent) 121 72 59
Ozone depletion potential from refrigeration and other ancillary uses (tonnes CFC-11 equivalent) 6.4 2.3 2.3
Volatile organic compound emissions (thousand tonnes) 6.6 6.5 5.5
Global warming potential from energy sources (thousand tonnes CO2 equivalent) 1,839 1,833 1,750
Hazardous waste disposed (thousand tonnes) 61.9 60.9 73.7
Health and Safety
Lost time injury and illness rate (cases per 100,000 hours worked) 0.34 0.30 0.30
Lost time injury and illness rate for contactors working on site (cases per 100,000 hours worked) 0.5 0.33 0.40
Valuing People
Women in management grades (%) 32 34 35
Ethnic diversity - people of colour (US, %) 19 19.5 19.5
Ethnic diversity - ethnic minorities (UK, %) - - 19.8
Research & development
GSK animal research facilities accredited by the Association for Assessment and Accreditation of Laboratory Animal Care 7 7 10
Number of trials published on GSK Clinical Trial Register - - 143
* Back to top